Which of the following is known as peakless insulin?
**Core Concept**
Insulin analogs are modified forms of human insulin designed to have specific pharmacokinetic profiles. A key characteristic of these analogs is their onset and duration of action, which can be tailored to mimic the natural insulin secretion pattern.
**Why the Correct Answer is Right**
Lispro insulin, a rapid-acting insulin analog, is known as peakless insulin because it does not have a pronounced peak in its action profile. This is due to its rapid onset of action, which allows it to closely mimic the natural insulin secretion pattern seen in healthy individuals. Lispro insulin starts to work within 15 minutes of injection and reaches its maximum effect within 1 hour, but its action profile is relatively flat and does not exhibit a distinct peak.
**Why Each Wrong Option is Incorrect**
**Option A:** Aspart insulin is another rapid-acting insulin analog, but it does have a more pronounced peak in its action profile compared to lispro insulin.
**Option B:** Glargine insulin is a long-acting insulin analog that has a flat action profile, but it is not considered peakless due to its delayed onset of action.
**Option C:** Detemir insulin is a long-acting insulin analog with a flat action profile, but it is not considered peakless due to its delayed onset of action.
**Clinical Pearl / High-Yield Fact**
Insulin analogs like lispro insulin are designed to provide more flexibility in diabetes management, allowing for more precise control of blood glucose levels. They can be administered immediately before meals to help control postprandial glucose spikes.
**Correct Answer: C. Detemir insulin is a long-acting insulin analog with a flat action profile, but it is not considered peakless due to its delayed onset of action.